Status:
COMPLETED
H&N Cancer; Survivorship and Late Effects
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo
Conditions:
Head and Neck Neoplasms
Survivorship
Eligibility:
All Genders
18+ years
Brief Summary
A cross-sectional study on late effects after modern treatment in long-term survivors of head and neck cancer (HNC). Participants fill in questionnaires and participate at a one day visit at the hospi...
Detailed Description
The purpose of this study is to provide knowledge on late effects and mortality risk after modern treatment in long-term survivors of head and neck cancer (HNC). This will allow adjustments of treatme...
Eligibility Criteria
Inclusion
- Histologically or cytologically verified invasive carcinoma of the head and neck region; ICD10: C01, C02.0 - C02.9; C03.0 - C03.9; C04.0 - C04.9; C05.0 - C05.9; C06.0 - C06.9; C07; C08.0 - C08.9; C09.0 - C09.9; C10.0 - C10.9; C11.0 - C11.9; C12; C13.0 - C13.9; C14.0 - C14.9; C30; C31.0 - C31.9; C32.0 - C32.9, C77.0
- Diagnosed 2006- 2012
- Ability to understand and respond to the questionnaires
- Ability to attend the clinical examination
- Informed consent received
Exclusion
- Unwillingness to answer HRQL questionnaires
- Patients under ongoing treatment for secondary cancer or relapse at the time of the survey
Key Trial Info
Start Date :
October 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2020
Estimated Enrollment :
265 Patients enrolled
Trial Details
Trial ID
NCT04758026
Start Date
October 10 2018
End Date
October 10 2020
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, N-0424